Clinical Trials Directory

Trials / Completed

CompletedNCT03401892

Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Ischemic optic neuropathy is among the most common causes of serious impaired vision in the middle-aged and elderly population in the western world. The current study focuses on a subgroup of ischemic optic neuropathy, the so-called non-arteritic ischemic optic neuropathy (NAION). Although the exact pathogenesis of NAION has not been fully clarified it is known that patients with cardio-vascular risk factors such as hypertension, diabetes mellitus and dyslipidemia have also an increased risk to develop NAION. Along this line of thought it has been shown that patients with a history of NAION in one eye have an increased risk to develop NAION also on the contralateral eye. However, clinical studies investigating ocular perfusion abnormalities in patients with NAION are sparse and even contradicting. Thus, the current study seeks to measure ocular blood flow parameters in patients with a history of NAION and compare it to healthy age-matched subjects.

Conditions

Interventions

TypeNameDescription
DEVICEDynamic Vessel Analyzer (DVA)Retinal vessel diameters and oxygen saturation will be measured with the DVA device.
DEVICEFourier Domain Doppler Optical Coherence Tomography (FDOCT)Retinal blood flow will be assessed using FDOCT.
DEVICEOptical coherence tomography (OCT)Nerve fiber layer thickness and central retinal thickness will be measured using OCT.

Timeline

Start date
2018-06-11
Primary completion
2018-06-11
Completion
2018-06-11
First posted
2018-01-17
Last updated
2021-09-01

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03401892. Inclusion in this directory is not an endorsement.